The amount absorbed depends on the route of administration or exposure, the compound’s molecular properties, and the condition of the tissues it encounters. Gastrointestinal, pulmonary, and dermal routes expose a substance to different biological barriers, while injection introduces it more directly. These differences can change the extent and pattern of systemic exposure.
After entering circulation, a compound may remain freely dissolved or bind to proteins in the blood. This binding affects how the substance is distributed through the body and how quickly it is cleared. Consequently, blood measurements may reflect both circulating free material and protein-associated material, which is important when interpreting systemic effects.
The route determines which biological barrier the compound encounters before reaching circulation and how tissue conditions influence absorption. Entry through the gastrointestinal tract, lungs, or skin may produce a different absorption pattern than direct injection. Comparing routes therefore helps explain differences in systemic exposure and supports more informed assessment of treatment or toxic exposure.
Blood concentrations provide a measurable link between administration and the amount of compound present in circulation. In medicine, these measurements support pharmacokinetic analysis by showing how exposure relates to systemic effects. They also provide a basis for evaluating whether observed concentrations are consistent with intended treatment or may indicate a potentially harmful exposure.
Clinicians and researchers use blood concentration information to connect a selected dose with the resulting systemic exposure. This supports dose selection and therapeutic drug monitoring, in which measured concentrations help assess whether treatment is producing an appropriate level of exposure. The approach can contribute to safer and more effective treatment decisions.
For toxic exposures, determining how a compound entered the body and measuring its blood concentration can clarify the extent of systemic exposure. Molecular properties, tissue conditions, and blood-protein binding may influence how the substance distributes and is cleared. These considerations help medicine relate the exposure pathway to potential systemic effects and support safety assessment.